All updated as on -
At a CAGR of 10.1% from 2023 to 2030, the global cell lysis & disruption market is predicted to increase from its 2022 valuation of $5,217.78M. Breaking open cells and releasing their contents are fundamental processes in molecular biology, biotechnology, and biochemistry. Protein and nucleic acid isolation, enzyme manufacturing, drug discovery, and bioprocessing are just few of the many uses for these methods.
This market has been expanding rapidly due to the increasing popularity of gene expression protocols and the widespread use of biotechnology in the food and agriculture sectors as well as the pharmaceutical industry. The current COVID-19 pandemic has contributed to the expansion of the market. Demand for bioprocessing technologies, such as cell lysis & disruption, has increased due to an uptick in research and development activities towards the creation of a vaccine for COVID-19. As a result, leading firms redirected their attention to providing solutions for the bioprocessing industry, resulting in significant revenue growth.
When trying to extract nucleic acids or proteins from a cell, cell lysis & disruption is a technique that involves breaking down the cell membrane. Different cell types, concentrations, applications (post-processing), and levels of efficiency call for different approaches when deciding how to lyse cells. As the biotechnology sector continues to expand its research and development efforts, so too does the need for cell lysis and disruption. The widespread implementation of biotech procedures in healthcare and agriculture is largely responsible for this. The market for cell lysis and disruption is benefiting from the growth of the biopharmaceutical industry and personalised medicine. Growth in the cell lysis and disruption market can also be attributed to the increased demand for innovative medicines and the overall rise in disease incidence.
Increases in public and private funding for research into biotechnology methods and academic study are anticipated to continue to considerably propel the market. The market is growing because there is a growing need for novel medicines and a rising incidence of diseases. Since cell lysis and disruption are required for the retrieval and purification of biopharmaceuticals, this sector's growth would open up new opportunities for the market. Furthermore, cell lysis bears major importance throughout the course of the bioprocess, which is why the market is likely to be driven by the adoption of biotech processes in the pharmaceutical, agricultural, and bio-services industries. New microfluidic-based devices have emerged in response to the growing need for efficient equipment to dissociate tumour tissue. Tumour tissues can be dissociated into single cells using microfluidic devices, which improves cell recovery in terms of both quantity and quality.
The study of pathogens and immunoassays in diagnostic laboratories; the understanding of protein structure and function; the diagnosis of cancer; the determination of the messenger ribonucleic acid transcriptome; and the investigation of the composition of lipids, nucleic acids, and proteins all require the lysis and disruption of cells. The increasing use of biotechnology in sectors such as agriculture, medicines, and bio-services is a key factor propelling the global cell lysis and disruption market. The market for cell lysis and disruption is growing rapidly due, in part, to the government's increasing efforts to encourage the widespread use of biotechnology-based screening alternatives and therapies.
Market expansion is anticipated to be driven by the rising incidence of cancer around the world. In 2020, there were approximately 19.3 million new instances of cancer and around 10 million deaths from cancer, as reported by the International Agency for Research on Cancer. The ability to lyse cells is crucial for both the detection of cancer and the research and development of new medications for its treatment. Because of the increasing number of people diagnosed with cancer and other infectious diseases, scientists are turning to cell lysis and disruption in their quest to find effective treatments. Demand for cell lysis and disruption is also being driven by their increasing use in academic and scientific institutions for research and development purposes.
Several topics involving cell lysis and disruption techniques are expanding rapidly for various reasons. The progress made in biotechnology has been a driving force in the development of new methods for disrupting and lysing cells. Cell lysis and disruption procedures are essential in many areas of biotechnology, such as recombinant protein manufacturing, gene expression analysis, genetic engineering, and bioprocessing. Cell lysis and disruption procedures are expanding due to rising demand for biologics including vaccines, enzymes, and antibodies, from which intracellular components are extracted for further processing. Drug research and development are also fueling the expansion of cell lysis and disruption methods. Extraction of cellular components is essential for researching drug-target interactions, drug metabolism, and pharmacokinetics, as well as for screening and characterising drug candidates. The need for effective cell lysis and disruption technologies is on the rise due to the rising need for innovative medication candidates and personalised treatment.
The field of cell lysis and disruption is anticipated to expand most rapidly in the downstream processing sector. Critical to many biotechnological and pharmaceutical processes is a stage known as "downstream processing," which involves isolating and purifying target chemicals from the disrupted cells. The cell lysis and disruption market is expanding, with the downstream processing segment leading the way. The uptake of personalised medicine is driving expansion in the downstream processing sector. Extraction and analysis of genetic material from patient samples are essential steps in the pursuit of personalised medicine's goal of providing customised treatment options based on an individual's genetic makeup. The purification of DNA and RNA, as well as other genetic materials, requires the lysis or rupture of cells. The need for cell lysis and disruption downstream processing procedures is anticipated to be driven by the rising use of personalised medicine.
Report Coverage
Global Cell Lysis & Disruption research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Cell Lysis & Disruption report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Cell Lysis & Disruption competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Cell Lysis & Disruption market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Cell Lysis & Disruption market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Cell Lysis & Disruption market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Becton Dickinson & Company (BD), Bio-Rad Laboratories, BioVision, Inc., Cell Signaling Technology Inc., Claremont BioSolutions, LLC, Covaris, Danaher Corp., Roche Molecular Systems, Inc., Geno Technology Inc., Merck KGaA, Microfluidics International Corp., Miltenyi Biotec, Norgen Biotek Corp., NZYTech Lda, Parr Instrument Company, PromoCell GmbH, Qsonica LLC, STEMCELL Technologies Inc., and Thermo Fisher Scientific.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Cell Lysis & Disruption market based on the below-mentioned segments:
Global Cell Lysis & Disruption Market, By Technique
Reagent Based
Physical Disruption
Global Cell Lysis & Disruption market, By Application
Consumables
Inst
Global Cell Lysis & Disruption Market, By Cell Type
Mammalian Cells
Microbial Cells
Global Cell Lysis & Disruption market, Regional Analysis
This market has been expanding rapidly due to the increasing popularity of gene expression protocols and the widespread use of biotechnology in the food and agriculture sectors as well as the pharmaceutical industry. The current COVID-19 pandemic has contributed to the expansion of the market. Demand for bioprocessing technologies, such as cell lysis & disruption, has increased due to an uptick in research and development activities towards the creation of a vaccine for COVID-19. As a result, leading firms redirected their attention to providing solutions for the bioprocessing industry, resulting in significant revenue growth.
When trying to extract nucleic acids or proteins from a cell, cell lysis & disruption is a technique that involves breaking down the cell membrane. Different cell types, concentrations, applications (post-processing), and levels of efficiency call for different approaches when deciding how to lyse cells. As the biotechnology sector continues to expand its research and development efforts, so too does the need for cell lysis and disruption. The widespread implementation of biotech procedures in healthcare and agriculture is largely responsible for this. The market for cell lysis and disruption is benefiting from the growth of the biopharmaceutical industry and personalised medicine. Growth in the cell lysis and disruption market can also be attributed to the increased demand for innovative medicines and the overall rise in disease incidence.
Increases in public and private funding for research into biotechnology methods and academic study are anticipated to continue to considerably propel the market. The market is growing because there is a growing need for novel medicines and a rising incidence of diseases. Since cell lysis and disruption are required for the retrieval and purification of biopharmaceuticals, this sector's growth would open up new opportunities for the market. Furthermore, cell lysis bears major importance throughout the course of the bioprocess, which is why the market is likely to be driven by the adoption of biotech processes in the pharmaceutical, agricultural, and bio-services industries. New microfluidic-based devices have emerged in response to the growing need for efficient equipment to dissociate tumour tissue. Tumour tissues can be dissociated into single cells using microfluidic devices, which improves cell recovery in terms of both quantity and quality.
The study of pathogens and immunoassays in diagnostic laboratories; the understanding of protein structure and function; the diagnosis of cancer; the determination of the messenger ribonucleic acid transcriptome; and the investigation of the composition of lipids, nucleic acids, and proteins all require the lysis and disruption of cells. The increasing use of biotechnology in sectors such as agriculture, medicines, and bio-services is a key factor propelling the global cell lysis and disruption market. The market for cell lysis and disruption is growing rapidly due, in part, to the government's increasing efforts to encourage the widespread use of biotechnology-based screening alternatives and therapies.
Market expansion is anticipated to be driven by the rising incidence of cancer around the world. In 2020, there were approximately 19.3 million new instances of cancer and around 10 million deaths from cancer, as reported by the International Agency for Research on Cancer. The ability to lyse cells is crucial for both the detection of cancer and the research and development of new medications for its treatment. Because of the increasing number of people diagnosed with cancer and other infectious diseases, scientists are turning to cell lysis and disruption in their quest to find effective treatments. Demand for cell lysis and disruption is also being driven by their increasing use in academic and scientific institutions for research and development purposes.
Several topics involving cell lysis and disruption techniques are expanding rapidly for various reasons. The progress made in biotechnology has been a driving force in the development of new methods for disrupting and lysing cells. Cell lysis and disruption procedures are essential in many areas of biotechnology, such as recombinant protein manufacturing, gene expression analysis, genetic engineering, and bioprocessing. Cell lysis and disruption procedures are expanding due to rising demand for biologics including vaccines, enzymes, and antibodies, from which intracellular components are extracted for further processing. Drug research and development are also fueling the expansion of cell lysis and disruption methods. Extraction of cellular components is essential for researching drug-target interactions, drug metabolism, and pharmacokinetics, as well as for screening and characterising drug candidates. The need for effective cell lysis and disruption technologies is on the rise due to the rising need for innovative medication candidates and personalised treatment.
The field of cell lysis and disruption is anticipated to expand most rapidly in the downstream processing sector. Critical to many biotechnological and pharmaceutical processes is a stage known as "downstream processing," which involves isolating and purifying target chemicals from the disrupted cells. The cell lysis and disruption market is expanding, with the downstream processing segment leading the way. The uptake of personalised medicine is driving expansion in the downstream processing sector. Extraction and analysis of genetic material from patient samples are essential steps in the pursuit of personalised medicine's goal of providing customised treatment options based on an individual's genetic makeup. The purification of DNA and RNA, as well as other genetic materials, requires the lysis or rupture of cells. The need for cell lysis and disruption downstream processing procedures is anticipated to be driven by the rising use of personalised medicine.
Report Coverage
Global Cell Lysis & Disruption research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Cell Lysis & Disruption report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Cell Lysis & Disruption competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Cell Lysis & Disruption market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Becton Dickinson & Company (BD), Bio-Rad Laboratories, BioVision, Inc., Cell Signaling Technology Inc., Claremont BioSolutions, LLC, Covaris, Danaher Corp., Roche Molecular Systems, Inc., Geno Technology Inc., Merck KGaA, Microfluidics International Corp., Miltenyi Biotec, Norgen Biotek Corp., NZYTech Lda, Parr Instrument Company, PromoCell GmbH, Qsonica LLC, STEMCELL Technologies Inc., and Thermo Fisher Scientific. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Cell Lysis & Disruption Market from 2021 to 2030.
- Market Forecast for Cell Lysis & Disruption Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Cell Lysis & Disruption competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Cell Lysis & Disruption
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Cell Lysis & Disruption market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Cell Lysis & Disruption market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Becton Dickinson & Company (BD), Bio-Rad Laboratories, BioVision, Inc., Cell Signaling Technology Inc., Claremont BioSolutions, LLC, Covaris, Danaher Corp., Roche Molecular Systems, Inc., Geno Technology Inc., Merck KGaA, Microfluidics International Corp., Miltenyi Biotec, Norgen Biotek Corp., NZYTech Lda, Parr Instrument Company, PromoCell GmbH, Qsonica LLC, STEMCELL Technologies Inc., and Thermo Fisher Scientific.
Primary Target Market
- Market Players of Cell Lysis & Disruption
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Cell Lysis & Disruption market based on the below-mentioned segments:
Global Cell Lysis & Disruption Market, By Technique
Reagent Based
Physical Disruption
Global Cell Lysis & Disruption market, By Application
Consumables
Inst
Global Cell Lysis & Disruption Market, By Cell Type
Mammalian Cells
Microbial Cells
Global Cell Lysis & Disruption market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive cell lysis disruption market market research and competitor analysis for your business to help you develop more profound insights into the cell lysis disruption market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the cell lysis disruption market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.